Ikena Oncology Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Ikena Oncology stock have an average target of 3.00, with a low estimate of 2.00 and a high estimate of 4.00. The average target predicts an increase of 74.42% from the current stock price of 1.72.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.00	$3.00	$4.00	$4.00
Change	+16.28%	+74.42%	+132.56%	+132.56%

Analyst Ratings

The average analyst rating for Ikena Oncology stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jun '24	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Andres Maldonado HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $4	Strong Buy	Reiterates	$4	+132.56%	Nov 11, 2024
Andres Maldonado HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $4	Strong Buy	Reiterates	$4	+132.56%	Aug 12, 2024
David Nierengarten Wedbush	Wedbush	Buy → Hold Downgrades $8 → $2	Buy → Hold	Downgrades	$8 → $2	+16.28%	May 29, 2024
Andres Maldonado HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $11 → $4	Strong Buy	Maintains	$11 → $4	+132.56%	May 29, 2024
David Nierengarten Wedbush	Wedbush	Buy Reiterates $8	Buy	Reiterates	$8	+365.12%	May 14, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 9.16M

Revenue Next Year

n/a

EPS This Year

-1.12

from -1.63

EPS Next Year

-0.87

from -1.12

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	13.75M	9.19M	30.99M	15.62M	9.16M	-	-	-
Revenue Growth	1,289.19%	-33.15%	237.01%	-49.59%	-41.35%	-	-	-
EPS	-6.35	-16.00	-1.22	-1.90	-1.63	-1.12	-0.87	-0.80
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	6	5	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	n/a	n/a	n/a
Avg	n/a	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2024	2025	2026
High	-1.01	-0.64	-0.54
Avg	-1.12	-0.87	-0.80
Low	-1.17	-1.06	-1.06

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.